The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
Welcome to The Lymphoma Channel
VJHemOnc brings you key updates in aggressive NK- and T-cell lymphomas directly from leading researchers. The Aggressive T-cell & NK-cell Lymphoma Channel covers pivotal updates presented at major international congresses so that you can stay up-to-date through video interviews, podcasts and roundtable discussions with leading experts.
Peripheral T-Cell Lymphoma
View all
The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).
Diamond Supporter
Gold Supporter
Silver Supporter
Bronze Supporter
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
If you are interested in becoming a supporter of The Lymphoma Channel, please contact us.
